Ira J. Chasnoff, M.D.
Dr. Chasnoff and the team at CRT opened and operated a laboratory preschool classroom to develop specific interventions for children prenatally exposed to alcohol and other drugs and developed a model Head Start Family Service Center for children and their families at risk from drugs and the drug-seeking environment. In addition, Dr. Chasnoff and the CRT research team were one of five national sites conducting research into the integration of behavioral health interventions into primary health care services for high-risk children and their families, and through this project they studied the impact of concurrent planning on permanency placement for children in the foster care system. Since 2002, Children's Research Triangle under Dr. Chasnoff’s leadership has been working with the Centers for Disease Control as one of four national centers for research into innovative treatment for children with Fetal Alcohol Syndrome.
Dr. Chasnoff’s most recent work focuses on community approaches to the integration of behavioral health services into primary health care for women and children and the occurrence of co-occurring mental health disorders in children who have been exposed to alcohol, methamphetamine, cocaine, and other drugs. As an extension of these efforts, Dr. Chasnoff is working with communities and States to develop integrated systems of prevention and care for children and families affected by substance abuse. In addition, Dr. Chasnoff has served as the Chair of the National Medical Task Force on Methamphetamine, Children, and Families for the Congressionally authorized National Alliance on Model State Drug Laws and served as the Chair of the State Task Force on FASD for the State of Illinois. In November 2008, Dr. Chasnoff was appointed to the US Department of Health and Human Services’ Interagency Coordinating Council on FASD, the federal committee tasked with the coordination of national efforts to address prenatal alcohol exposure and its health and fiscal impact on the U.S. population. Through this work, Dr. Chasnoff is part of the national effort to define the neurodevelopmental profile of children across the fetal alcohol spectrum.